Notably, SIRT3 expression was decreased by 5-Fu treatment in 5-Fu sensitive tumor cells, but not in 5-Fu-resistant cells, indicating that the SIRT3-ALDH1L2 axis is associated with the response of cancer cells to 5-Fu treatment. Here, ALDH1L2 is linked to neoplasm.